Tissue Repair & Regeneration
Palmitoyl Tetrapeptide-7

Most anti-ageing peptides argue about collagen. Palmitoyl tetrapeptide-7 argues about inflammation: the case for it is that it lowers interleukin-6, the messenger skin cells release after ultraviolet exposure, which would blunt one of the routes by which sun damages skin over years. It is best known as half of Matrixyl 3000 and is almost always sold blended with palmitoyl tripeptide-1. The clean test has never been run, and this record names the gaps rather than glossing them: no study on file isolated the ingredient from its blend, no randomised trial of it exists, and the concentration figures on ingredient lists come from suppliers rather than from any trial that varied the dose.
Last updated
Mechanism
Reduces interleukin-6 secretion by skin cells after UVB exposure, and is associated with laminin and collagen VII synthesis.
Reported effects
What sources associate with this compound. Reported categories, not outcomes we have graded — each would need its own citation and rung.
- Inflammatory response research
- Photoageing context
- Dermal-epidermal junction support
Manufacturer’s claim vendor marketing
For a proprietary cosmetic ingredient the manufacturer is the originator — there is no upstream to defer to, and this is often the only description that exists. It is reproduced as an attributed claim, with the label its source gave it. It is not graded and it is not evidence — the graded studies are under Literature.
Vendor claims quoted from fetched page: "collagen-boosting properties that target wrinkles and fine lines"; "restore the skin's firmness and elasticity by supporting the skin's structural components"; "reduce fine lines, wrinkles, and sagging skin by promoting collagen production". No n= or study duration given on fetched page.
- Manufacturer
- Croda (Sederma brand)
- Sold as
- Matrixyl 3000 (blend with Palmitoyl Tripeptide-1); also ActiTide 3000 (Uniproma), Haloxyl (distributed by Brenntag)
- Manufacturer’s recommended use
- Vendor claim: "generally used in concentrations of 2% to 5% in formulations"
Source page — nofollow, because a vendor link is a reference here, not an endorsement.
Dosing on file unverified
0.1-0.5% in creams, 1-2x/day
Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.
Literature on file 4
-
human observational
Evaluation of dermal extracellular matrix and epidermal-dermal junction modifications using matrix-assisted laser desorption/ionization mass spectrometric imaging, in vivo reflectance confocal microscopy, echography, and histology: effect of age and peptide applications graded on: peptide and placebo applied to human skin and compared by in-vivo confocal microscopy and MALDI imaging; no randomisation stated — read from the abstract — “abstract review”
-
human RCT
Comprehensive evaluation of the efficacy and safety of a new multi-component anti-aging topical eye cream graded on: names a randomised controlled trial — the indexed publication type — “Randomized Controlled”
-
animal in vivo
Injectable polypeptide/chitosan hydrogel with loaded stem cells and rapid gelation promoting angiogenesis for diabetic wound healing graded on: an animal model — read from the indexed abstract — “mice”
Not graded
1 citation whose study design could not be read from the title. Left ungraded rather than guessed at.
-
not graded
NCT05932732: A Phase IV Open-label Trial Assessing the Impact on Skin Quality, Hydration, and Barrier of Three (3) Hydrafacial Treatments in Adults of Fitzpatrick Skin Types I-VI graded on: NCT05932732 is completed and has posted no results - a registration, not a reported outcome — “NCT05932732”
Identity
Skeletal formulathe canonical depiction
Drawn by PubChem from CID 10078408, the identifier on this record.
- Molecular weight
- 694.9
- Molecular formula
- C34H62N8O7
- CAS number
- 221227-05-0
- PubChem CID
- 10078408
- InChI key
- IHRKJQSLKLYWBQ-QKDODKLFSA-N
- SMILES
- CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)O
- InChI
- InChI=1S/C34H62N8O7/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-19-29(44)39-24-30(45)40-25(20-21-28(35)43)32(47)42-23-16-18-27(42)31(46)41-26(33(48)49)17-15-22-38-34(36)37/h25-27H,2-24H2,1H3,(H2,35,43)(H,39,44)(H,40,45)(H,41,46)(H,48,49)(H4,36,37,38)/t25-,26-,27-/m0/s1
Also called
- ActiTide 3000
- Matrixyl 3000
- Palmitoyl Tetrapeptide-7
Notes unverified prose
12-week clinical trial: skin hydration +28.12%, elasticity +18.81%, collagen +54.99%; Matrixyl 3000 blend; Phase 4; NCT05932732; Clinical trials in JCAD
Not on file 5
1 of the 8 fields we track hold nothing on this record, and each says why. 4 further absences are named below. A blank field is a bug; a named absence is a finding.
- amino-acid sequencenothing we hold supplies it
- half-lifenothing we hold supplies it
- single agent evidenceevery human record on file tested palmitoyl tetrapeptide-7 inside a blend or a finished formulation; no study isolated it
- randomised human trialno randomised trial of this ingredient is on file
- effect size by concentrationthe 0.1-0.5% and 2-5% use figures on file come from suppliers, not from a trial that varied concentration
Each field links to every other record missing the same thing. The full ledger holds 765 gaps across 163 records.
Listed prices 5
What 5 shops we track listed for Palmitoyl Tetrapeptide-7, read from their own public catalogues on 2026-09-14. We take no commission on these and they are not ranked by any payment — how vendors are scored.
Compare prices5 listings from 5 shops
| Vendor | Size | Price | Per mg |
|---|---|---|---|
| Raw Amino | 200 mg | $184.00 USD | $0.92/mg |
| Core Peptides | 200 mg | $197.00 USD | $0.98/mg |
| USA Peptide Sciences | 200 mg | $200.00 USD | $1.00/mg |
| Vendor | Size | Price | Per mg |
|---|---|---|---|
| Peptide Shop Canada | 200 mg | $123.30 CAD | $0.62/mg |
| Core Peptides Canada | 200 mg | $242.90 CAD | $1.21/mg |
None of these shops lists your destination. Choose “Show all” to see every listing we hold.
Prices are the vendor's own listing, reproduced with the date we read it — never converted between currencies, and compared per milligram only where the vendor states the vial size.